Home / Virus / qz : declared in HIV prevention: New injectable drug for PrEP could be a ‘game-changer’
alibaba.com, cpa campaign, lead generation, lead campaign, smart match lander, intelligent lander, a

qz : declared in HIV prevention: New injectable drug for PrEP could be a ‘game-changer’

This content may collect you by Sofia Jackson

We will quote to you most important and trendy news about HIV of the best health sites Like : “qz” and the most famous medical experts : Neha Thirani Bagri

daily : 2017-01-02 & on time : 20:41

As it stated in

Bill and Melinda Gates are now backing a tiny implantable drug pump from Intarcia designed to prevent HIV infection — Quartz

Bill and Melinda Gates are now backing a tiny implantable drug pump from Intarcia designed to prevent HIV infection — Quartz

image uploaded by “qz” site

In sub-Saharan Africa, the human immunodeficiency virus (HIV) is an epidemic that shows no signs of relenting.In 2013, an estimated 24.7 million people in the region were living with HIV, accounting for 71% of the global total.Worldwide, 2.1 million people became newly infected with HIV in 2015, according to UNAIDS.

about the details read more from here

First human trials of long-acting injectable drug to prevent HIV underway / LGBTQ Nation

First human trials of long-acting injectable drug to prevent HIV underway / LGBTQ Nation

image uploaded by “lgbtqnation” site

A study that’s been called the first large-scale clinical trial of an injectable drug for HIV prevention — one that will remain effective for a far longer period than the daily PrEP regimen — is now underway.It involves 4,500 men who have sex with men, as well as transgender women who have sex with men.They hail from 45 spots around the world: eight countries in the Americas, Asia and Africa.

about the details read more from here

HIV prevention: New injectable drug for PrEP could be a ‘game-changer’

HIV prevention: New injectable drug for PrEP could be a 'game-changer'

image uploaded by “ibtimes” site

A clinical trial has just been launched to test the efficacy of a new injectable drug to protect men who have sex with men and transgender women from becoming infected with HIV.Known as the HPTN 083 study, it aims to improve the prevention tools available to the demography that are most vulnerable to the virus.HIV pre-exposure prophylaxis is a preventive measure that involves people who are at very high risk for HIV – such as sexually active gay men – taking a combination of two oral HIV medicines sold under the name Truvada, on a daily basis.

about the details read more from here

To follow all the new news about Viruses

Check Also

picture.jpg

influenza season off to an early – & nasty – begain

according to This year’s influenza season is off to a quick begain & Extremely far …